Registered Nurse (RN) - Director Hospice - $70K-90K per year Elara Caring
- $70,000–$90,000 Per Year
Company Overview
Our Mission: At Esperion, we are working tirelessly to deliver innovative medicines that help patients reach their goals today, tomorrow, and into the future.
Esperion is a fully remote based company with a corporate headquarters located in Ann Arbor, MI. The Company offers a competitive salary including a performance-based bonus program and stock-based compensation, a comprehensive benefits package including a 401(k) matching plan and health insurance, and paid time off and holidays.
Position Title: Director, Government Pricing
This role serves as a key contributor to the Contracting and Pricing function, providing direct support to the Executive Director and ensuring the accurate, timely execution of government and commercial contract administration. The position is responsible for the end-to-end data lifecycle-preparation, validation, calculation, and analytics-underpinning compliance with all federal and state government pricing programs.
Preferred Location: Remote - US
Essential Duties and Responsibilities*
Qualifications (Education & Experience)
| Location | Ann Arbor, MI (Remote) |
| Industry | Biotechnology/Pharmaceuticals |
| Company Size | 100 to 499 employees |
| Year Founded | 2008 |
| Website | http://www.esperion.com |
At ESPERION, we’re committed to changing that. Read about our mission and our core values.
We have assembled a world-renowned team of lipid specialists who have been at the forefront of innovation in lipid management for decades.
Our goal: to help patients who still need additional lipid lowering despite taking maximally tolerated statin therapy. With this goal in mind, we are driven to provide patients a novel treatment that not only works to lower LDL-C, but also works safely within their bodies.
Every day, we are focused on this lone objective. Because we believe that to change this treatment paradigm, our company would rather be excellent in just this one disease state, than be good in several.
Our approach is unprecedented in modern pharmaceuticals, and we think it is the right one.

